Latest News in the pharma Industry

All

Positive update on the development of new XF‐platform drug formulations

Positive update on the development of new XF‐platform drug formulations

24 Mar 2020

Collaboration with MedPharm delivers data profiling new XF‐platform drug formulations as potential treatments for dermal and ocular infections.

Read more 
ProBioGen selected for development and large-scale manufacturing services

ProBioGen selected for development and large-scale manufacturing services

24 Mar 2020

The Contract Development and Manufacturing Organization (CDMO) and technology provider will use its CHO.RiGHT expression platform for high-titer cell line development.

Read more 
Thermo Fisher to invest more than $475 million this year on capacity and capability expansion

Thermo Fisher to invest more than $475 million this year on capacity and capability expansion

23 Mar 2020

Thermo Fisher Scientific will invest more than USD475 million in 2020 in new capabilities and capacity to meet increasing demand for biologics, cell and gene therapies and drug products, the contract development and manufacturing organisation said Mond...

Read more 
What impact will coronavirus have on pharma supply chains?

What impact will coronavirus have on pharma supply chains?

23 Mar 2020

Our content has now moved to our new Global Pharma Insights website, providing the very latest news and information covering all aspects of the pharmaceutical supply chain. Please click the link below to access this article.

Read more 
Codexis and Takeda collaborate to advance novel gene therapies

Codexis and Takeda collaborate to advance novel gene therapies

23 Mar 2020

Partnership to leverage Codexis’ protein engineering platform for the discovery and development of novel transgenes for lysosomal storage disorders and blood factor deficiencies.

Read more 
Lonza's new medium boosts and optimizes AAV production in insect cells

Lonza's new medium boosts and optimizes AAV production in insect cells

23 Mar 2020

The TheraPEAK SfAAV Medium is specifically designed to support the development of safe, scalable, gene therapies.

Read more 
Helsinn receives European approval of its IV formulation of Akynzeo

Helsinn receives European approval of its IV formulation of Akynzeo

23 Mar 2020

The new formulation offers patients in Europe an alternative route of administration of the only fixed antiemetic combination targeting two distinct CINV pathways in a single dose.

Read more 
FDB to triple UK microbial production capacity as Fujifilm commits to $83 million investment

FDB to triple UK microbial production capacity as Fujifilm commits to $83 million investment

19 Mar 2020

Fujifilm Diosynth Biotechnologies will triple microbial production capacity at its UK Teesside facility after joint owner Fujifilm Corporation pledged to invest 9 billion yen (USD83 million) in the biologics focused CDMO.

Read more 
Oxford Biomedica signs LSA with Juno Therapeutics

Oxford Biomedica signs LSA with Juno Therapeutics

19 Mar 2020

Cell and gene focused CDMO Oxford Biomedica (OXB) has signed a licence and clinical supply agreement which could be worth up to USD227 million with Juno Therapeutics, the firms announced Wednesday.

Read more 
Univercells launches new cell and gene focused CDMO Exothera

Univercells launches new cell and gene focused CDMO Exothera

19 Mar 2020

A new contract development and manufacturing organisation to support cell and gene developers with process development and production of viral vectors has been launched by bioprocessing provider Univercells.

Read more 
Fujifilm Diosynth Biotechnologies appoints Christine Vannais COO of North Carolina site

Fujifilm Diosynth Biotechnologies appoints Christine Vannais COO of North Carolina site

17 Mar 2020

Fujifilm Diosynth Biotechnologies has appointed Christine Vannais as chief operating officer at its North Carolina site, the biologics focused CDMO said Monday.

Read more 
CPhI announces new pharma events calendar for 2020

CPhI announces new pharma events calendar for 2020

17 Mar 2020

Organizers secure three new dates for events in Japan, South East Asia and North America in response to COVID-19.

Read more